Concepedia

Publication | Open Access

Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

DOIFull Paper Access

11

Citations

0

References

2019

Year

Scott T. Tagawa, Joseph R. Osborne, Amy Hackett, Muhammad Junaid Niaz, Victoria Cooley, Paul J. Christos, Panagiotis J. Vlachostergios, Charlene Thomas, Lauren Gracey, Himisha Beltran,
Annals of Oncology

No additional data available for this publication yet. Check back later!